Login Register

Healthcare

00:00:00
Biomerica seeing their colorectal cancer screening test as a game changer - Zack Irani, CEO, Biomerica Inc
00:00:00
René C. Goehrum | Chairman, President & Chief Executive Officer, Biosyent Inc
00:00:00
How dermatology company is improving the lives of patients suffering from skin diseases- Matt Callahan Executive Director, Botanix Pharmaceuticals Ltd
00:00:00
Developing autologous stem cell therapies for debilitating neurodegenerative diseases - Lebovits, CEO, Brainstorm Cell Therapeutics Inc
00:00:00
Clive Dix BSc PhD HonFBPhS, CEO, C4X Discovery Holdings PLC
00:00:00
Enrolling patients in its coronavirus-induced lung damage treatment study - David Mazzo, CEO, Caladrius Biosciences Inc
00:00:00
Interview with David Reeves, MD - Calidus Resources Ltd
00:00:00
Talk about the partnerships in the success of Project LEILAC and the Calix technology - Phil Hodgson Managing Director & CEO, Calix Ltd
00:00:00
Cambridge Cognition acquires virtual clinical trial firm eClinicalHealth - Dr Matthew Stork Chief Executive Officer, Cambridge Cognition Holdings
00:00:00
Test target cancers that are difficult to diagnose - Panna Sharma, CEO, Cancer Genetics Inc
00:00:00
Rav Mlait, MBA CEO, Director, Cannabix Technologies Inc
00:00:00
Cantargia's CEO Göran Forsberg presents the company- Göran Forsberg, CEO, Cantargia
00:00:00
Developing transformative cell and exosome-based therapeutics to treat muscular diseases - Linda Marbán, Ph.D. Chief Executive Officer and Director, Capricor Therapeutics Inc
00:00:00
Predictive modeling driven behavioral healthcare services to health plans - Terren Peizer, Chairman & CEO of Catasys, Inc.
00:00:00
Ceapro using patented technology to disrupt the natural health care products - Gilles Gagnon, President and Chief Executive Officer, Ceapro
00:00:00
CEL-SCI Corp letter to shareholders details positive results from Phase 3 study of Multikine - Geert R. Kersten Director and Chief Executive Officer, CEL-SCI Corp

© 2017 - Townhall + Tv